Seattle will be the place to be on September 27 and 28, when male contraception researchers from the U.S. and overseas gather to present their news. The second Future of Male Contraception conference - sponsored by the National Institute of Child Health and Human Development, CONRAD, the World Health Organization, and the University of Washington - will be at Seattle's Edgewater Hotel overlooking the Puget Sound. Registration is free of charge.
Here is a sample of the news to be announced at the conference:
- a new compound that can be taken orally (Columbia University, Retinoic acid alpha receptor inhibitor)
- 3-month and 6-month results in men for the Intra Vas Device, a vasectomy alternative (Shepherd Medical Company)
- Gamendazole: how it works in animals, and finding the right dose (University of Kansas and University of Minnesota)
- clinical proof-of-concept studies on testosterone alternatives for use in a "male pill" (GTx, Inc., SARMs)
- evidence of public demand, including survey results (International Male Contraception Coalition)
Many other teams will present late-breaking news during the poster session, 7-9 pm September 27th.
For further information, see the conference website: http://www.
The Future of Male Contraception
September 27-28, 2007
Registration and Information:
Meeting sponsored by:
National Institute of Child Health and Human Development
National Institutes of Health
World Health Organization
University of Washington
The Male Contraception Information Project (MCIP) is entirely nonprofit and works in three areas: raising public awareness of promising nonhormonal male contraceptives, advocating increased and expedited government research, and serving as a resource for journalists who wish to write about the subject. MCIP will be in attendance at the Future of Male Contraception conference and sending out press releases about selected developments. More resources for journalists are available from MCIP at www.NewMaleContraception.org.